Expression of progesterone receptor is a favorable prognostic marker in ovarian cancer (Q45274570)

11 December 2017

Expression of progesterone receptor is a favorable prognostic marker in ovarian cancer (English)

1 reference

11 December 2017

1 reference

Peng Lee

1

1 reference

11 December 2017

Daniel G Rosen

2

1 reference

11 December 2017

Changcheng Zhu

3

1 reference

11 December 2017

Elvio G Silva

4

1 reference

11 December 2017

Jinsong Liu

5

1 reference

11 December 2017

language of work or name

English

0 references

publication date

1 March 2005

1 reference

11 December 2017

1 reference

11 December 2017

96

1 reference

11 December 2017

3

1 reference

11 December 2017

671-677

1 reference

Estrogen, progesterone and epithelial ovarian cancer

11 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.11.010

Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.11.010

Progesterone receptor status is a significant prognostic variable of progression-free survival in advanced epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.11.010

Steroid receptors in ovarian carcinoma: immunohistochemical determination may lead to new aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.11.010

Progesterone receptor isoforms A and B in human epithelial ovarian carcinoma: immunohistochemical and RT-PCR studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.11.010

Steroid hormone receptors and long term survival in invasive ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.11.010

Importance of steroid receptors and aromatase activity in the prognosis of ovarian cancer: high tumor progesterone receptor levels correlate with longer survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.11.010

Survival of patients with ovarian cancer. Apart from stage and grade, tumor progesterone receptor content is a prognostic indicator.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.11.010

Epidermal growth factor, oestrogen and progesterone receptor expression in primary ovarian cancer: correlation with clinical outcome and response to chemotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.11.010

Clinical correlation of hormone receptor status in epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.11.010

Estrogen and progesterone receptor status as prognostic indicators in patients with optimally cytoreduced stage IIIc serous cystadenocarcinoma of the ovary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.11.010

Immunophenotype of ovarian cancer as predictor of clinical outcome: evaluation at primary surgery and second-look procedure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.11.010

Expression of human estrogen receptor-alpha and -beta, progesterone receptor, and androgen receptor mRNA in normal and malignant ovarian epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.11.010

Is endocrine status relevant to treatment planning in patients with gynaecological cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.11.010

An immunohistochemical evaluation of androgen and progesterone receptors in ovarian tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.11.010

Correlation between nuclear DNA content and steroid receptor status in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.11.010

Epithelial ovarian carcinoma: principles of primary surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.11.010

The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.11.010

Ovarian surface epithelial-stromal tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.11.010

Estrogen and anti-estrogen effects on the growth of human epithelial ovarian cancer in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.11.010

Incessant ovulation--a factor in ovarian neoplasia?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.11.010

Endogenous estrogens as carcinogens through metabolic activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.11.010

Estrogen and progesterone receptor subtype expression in normal and malignant ovarian epithelial cell cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.11.010

Absence of estrogen receptor-alpha expression in human ovarian clear cell adenocarcinoma compared with ovarian serous, endometrioid, and mucinous adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.11.010

WT1, estrogen receptor, and progesterone receptor as markers for breast or ovarian primary sites in metastatic adenocarcinoma to body fluids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.11.010

Progesterone-induced apoptosis in immortalized normal and malignant human ovarian surface epithelial cells involves enhanced expression of FasL

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.11.010

Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.11.010

Gene expression patterns in ovarian carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.11.010

7 January 2021

Histology of the ovary

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.11.010

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YGYNO.2004.11.010

1 reference

11 December 2017

1 reference